Survival outcome and perioperative complication related to neoadjuvant chemotherapy with carboplatin and paclitaxel for advanced ovarian cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Survival outcome and perioperative complication related to neoadjuvant chemotherapy with carboplatin and paclitaxel for advanced ovarian cancer: A systematic review and meta-analysis

Published:2020-05 Issue:5 Volume:46 Page:868-875
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Machida Hiroko,Tokunaga Hideki,Matsuo Koji,Matsumura Noriomi,Kobayashi Yoichi,Tabata Tsutomu,Kaneuchi Masanori,Nagase Satoru,Mikami Mikio

Funder

Ministry of Health, Labor and Welfare of Japan

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference54 articles.

1. Epidemiology of ovarian cancer: a review;Reid;Cancer biol med,2017

2. Epithelial ovarian cancer/fallopian tube cancer/primary peritoneal cancer and less common histopathologies;NCCN guideline version1,2019

3. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study;Eisenkop;Gynecol Oncol,2003

4. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study;Winter;J Clin Oncol : Off J Am Soc Clini Oncol,2008

5. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer;Aletti;Am J Obstet Gynecol,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review);Tumors of female reproductive system;2024-05-18

2. Association between alteration of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, cancer antigen-125 and surgical outcomes in advanced stage ovarian cancer patient who received neoadjuvant chemotherapy;Gynecologic Oncology Reports;2024-04

3. Research Progress of Neoadjuvant Chemotherapy for Advanced Ovarian Cancer;Advances in Clinical Medicine;2024

4. Preoperative Level of Insulin-Like Growth Factor Binding Protein 2 Predicts The Suboptimal Outcome After Primary Debulking Surgery in Patients with Advance Ovarian Cancer;The Indonesian Biomedical Journal;2023-12-11

5. CT-Based Radiomics for the Preoperative Prediction of Occult Peritoneal Metastasis in Epithelial Ovarian Cancers;Academic Radiology;2023-12